Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A kinase (PRKA) interacting protein 1 pseudogene (ENSG00000218730) is a non-coding genomic sequence related to the AKIP1 gene, which encodes a nuclear protein involved in cAMP-dependent protein kinase signaling and regulation of NF-kappa-B activation[4]. The pseudogene itself does not produce a functional protein, is not considered a therapeutic target, and has no significant molecular, biological, or clinical roles. If information was sought for a protein-coding target, refer instead to the AKIP1 gene, whose protein product is a nuclear regulator of protein kinase A signaling[4].\n\nKey clarification:\n- Pseudogenes like ENSG00000218730 do not encode active proteins and thus are not classified as therapeutic targets, such as receptors, enzymes, or transporters[4].\n- If you are seeking a pharmacologically or biologically relevant target, use the actual gene/protein: A kinase (PRKA) interacting protein 1 (AKIP1).\n\nThis entry is correct only for genomic annotation purposes. It is *not* a therapeutic/pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on A kinase (PRKA) interacting protein 1 pseudogene.